respectively.
Compound 3 was isolated as an amorphous powder and its molecular formula was determined to be C 25 H 42 O 13 by high resolution atmospheric pressure chemical ionization (HR-APCI) mass spectrometric analysis. The 13 C-NMR spectroscopic data showed the presence of two terminal b-D-glucopyranosyl units together with the remaining 13 carbon signals for the aglycone moiety, which was expected to have a megastigmane skeleton. The chemical shifts of this compound were closely related to those of sammangoside A (2), 10) except for a set of additional signals arising from one terminal b-D-glucopyranosyl unit. This additional unit was assigned to locate at C-3 of the aglycone part due to the downfield shift of this carbon atom ϩ8.3 ppm together with the upfield shifts of C-2 (Ϫ2.4 ppm) and C-4 (Ϫ3.2 ppm) in
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Tripetch KANCHANAPOOM,* ,a Hideaki OTSUKA, b and Somsak RUCHIRAWAT comparison with compound 2. In order to confirm the stereochemistry of the sugar unit and the absolute configurations at C-3 and C-9 of the aglycone moiety, compounds 2 and 3 were hydrolyzed with crude hesperidinase to provide aglycones 2a and 3a, in addition to two sugar fractions from aqueous layers. The stereochemistry of glucose of both compounds was determined to be D-form by treating the residue of two sugar fractions with L-cysteine methyl ester to provide the thiazolidine derivatives of sugars, and comparison of the Rf values with the standard samples of thiazolidine derivatives of D-glucose (see Experimental). Two aglycones were expected to present the same structure, and could be identical to each other as (3S,5R,6S,7E,9S)-megastigman-7-ene- 
Ϫ87.9°).
11) The absolute configurations at C-3 and C-9 were confirmed to be 3S and 9S, respectively, by the application of b-D-glucosylation shift effects on carbon chemical shifts of secondary hydroxyl groups and the upfield shift differences of their neighboring carbon atoms in the aglycone part (see Table 2 ).
12) Moreover, the appearance of the chemical shift of C-9 at 74.8 ppm is indicative of a 9S-configuration. 8, 13) Therefore, compound 3 was assigned as (3S,5R,6S,7E,9S)-megastigman-7-ene-5,6-epoxy-3,9-diol 3,9-O-b-D-diglucopyranoside.
The remaining isolated compounds from E. debile were identified as kaempferol 3-O-sophoroside (6) 
and L-tryptophan (12) by physical data and from spectroscopic evidence. 2, 3, 10, 14, 15) From the methanolic extract of the second species, E. diffusum, four compounds were isolated. Three were elucidated to be the same compounds as reported from E. debile; sammangaoside A (2), kaempferol 3-O-sophoroside (6) and Ltryptophan (12) .
Compound 13 was obtained as an amorphous powder, and its elemental composition was determined to be C 19 H 32 O 8 by HR-APCI mass spectrometric analysis. Inspection of the 13 C-NMR spectroscopic data revealed the presence of 13 carbon signals of the aglycone moiety together with six carbon signals of a b-D-glucopyranosyl unit, corresponding to a megastigmane glucoside. The chemical shifts of this compound were closely related to those of compounds 2, 3 and 2a. In particular, the chemical shifts of the ring system were in agreement with those of 3, and those of the side chain were compatible to those of 2a, suggesting that this compound prosessed the same aglycone moiety due to the co-occurrence of the same aglycone in the same species or genus, and the sugar part was connected to C-3. Enzymatic hydrolysis of 13 with crude herperidinase afforded 13a together with a sugar fraction from the aqueous layer. The stereochemistry of glucose was assigned to be D-form by the method described above. The chemical shifts and the optical rotation value ([a] D 29 Ϫ88.3°) of 13a were fully consistent with those of (3S,5R,6S,7E,9S)-megastigman-7-ene-5,6-epoxy-3,9-diol (2a or 3a). Consequently, the structure of compound 13 was assigned as (3S,5R,6S,7E,9S)-megastigman-7-ene-5,6-epoxy-3,9-diol 3-O-b-D-glucopyranoside. In fact, the structure of this compound was firstly reported with the trivial name corchoionoside A, which showed a 9S-configuration. 16 ) However, the structure of corchoionoside A was revised to have a 1278
Vol. 55, No. 8 9R-configuration, 17) which was identical with the structure of stratioside I.
18) It should be noted that compound 13 might not have been isolated for the first time since two isomeric compounds, 9S and 9R-configurations, provided the identical NMR spectroscopic data. Also, previous studies have reported the isolation of corchoionoside A, which indicated the presence of a 9S-configuration in the structure.
19-22)

Experimental
General Procedures NMR spectra were recorded in CD 3 OD using a JEOL JNM a-400 spectrometer (400 MHz for 1 H-NMR and 100 MHz for 4 g ) was separated on a column of RP-18 using solvent system V to give six fractions. Fraction 5-1 was further purified by preparative HPLC-ODS with solvent system VI to provide a new compound, (3S,5R,6S,7E,9S)-megastigman-7-ene-5,6-epoxy-3,9-diol 3,9-O-b-D-diglucopyranoside (3, 11.4 mg). Kaempferol 3-Osophoroside (6, 78.6 mg) was obtained from fraction 5-4 by crystallization. Fraction 6 (670.0 mg) was similarly separated on a column of RP-18 using solvent system V to afford six fractions, giving L-tryptophan (12, 22.1 mg), and kaempferol 3,7-O-b-D-diglucopyranoside (7, 14.6 mg) by crystallization from fractions 6-1 and 6-3, respectively. Finally, fraction 8 (1.36 g) was subjected to a column of RP-18 using solvent system V to provide kaempferol 3-O-sophoroside-7-O-b-D-glucopyranoside (8, 59 .4 mg) by crystallization from fraction 8-2.
The aerial portion of the second species, E. diffusum (595.0 g), was similarly extracted with MeOH, and concentrated to dryness. This part was suspended in H 2 O and partitioned with Et 2 O. The water layer was applied to a column of Diaion HP-20 and eluted with H 2 O, MeOH, and Me 2 CO, successively. The portion eluted with methanol (1.5 g) was repeatedly chromatographed on a column of silica gel using solvent systems I (500 ml), II (500 ml), III (500 ml) and IV (500 ml), respectively, to provide four fractions. Fraction 2 (378.2 mg) was applied to a column of RP-18 using solvent system V to give five fractions. Fraction 2-2 was purified by preparative HPLC-ODS with solvent system VII to yield (3S,5R,6S,7E,9S)-megastigman-7-ene-5,6-epoxy-3,9-diol 3-O-b-D-glucopyranoside (13, 6.3 mg) and sammangaoside A (2, 1.8 mg). Fraction 3 (536.0 mg) was similarly applied to a column of RP-18 using solvent system V to give L-tryptophan ( 2 mg) , 3 (10.0 mg) and 13 (6.0 mg) was hydrolyzed with crude hesperidinase (25 mg) in 2 ml of H 2 O. After stirring at 37°C for 48 h, the reaction mixtures were extracted with EtOAc, and then evaporated to dryness to afford (3S,5R,6S,7E,9S)-megastigman-7-ene-5,6-epoxy-3,9-diol (2a, 5.5 mg; 3a, 2.3 mg and 13a, 3.6 mg). The structure was identified by 
